SCHRODINGER SOFTWARE SUITE FULL

вЂњImportantly, our balance sheet and growing revenue enable us to make strategic investments in both our computational platform and our internal pipeline to build for the future.вЂќДelivered strong operating performance and strategic execution Looking across multiple key indicators, we believe our underlying business is poised for continued growth this year,вЂќ said Joel Lebowitz, chief financial officer at SchrГ¶dinger. вЂњWe finished 2020 in a strong financial position. We believe this growth reflects the power of our physics-based platform to accelerate the discovery of new medicines and materials,вЂќ stated Ramy Farid, Ph.D., chief executive officer at SchrГ¶dinger. Software revenue increased substantially, and we expect continued growth in 2021. вЂњ2020 was a very strong year for SchrГ¶dinger across all aspects of our business.

SCHRODINGER SOFTWARE SUITE FULL

(Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced financial results for the fourth quarter and full year ended December 31, 2020, and provided its financial outlook for 2021. Internal pipeline progressing, with plans to submit investigational new drug applications in 2022Д¬onference call today, Thursday, March 4, at 8:30 a.m. Strong financial position enables continued investment in advancing the science underlying SchrГ¶dingerвЂ™s computational platform Software revenue of $92.5 million in 2020, up 39 percent year-over-year Total revenue of $108.1 million in 2020, up 26 percent year-over-year

Schrodinger software suite